Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation

Critical Reviews in Biochemistry and Molecular Biology

Volumn 51, Issue 1, 2016, Pages 7-14

  Pontis, Silvia ^a   Ribeiro, Alison ^a   Sasso, Oscar ^a   Piomelli, Daniele ^a,b  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokines; enzyme inhibitors; fatty acid ethanolamides; macrophages; N acylethanolamine acid amidase; nuclear receptor

Indexed keywords

AMIDASE; ANTIINFLAMMATORY AGENT; CYSTEINE; ENZYME INHIBITOR; FATTY ACID; N OLEOYLETHANOLAMINE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

CHRONIC INFLAMMATION; COMPLEX FORMATION; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; INFLAMMATION; LYSOSOME; MACROPHAGE; MEDIATOR RELEASE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATION; LIPIDS; MACROPHAGES; PPAR ALPHA;

EID: 84956791661     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.3109/10409238.2015.1092944     Document Type: Review

References (69)

1. Alhouayek M, Bottemanne P, Subramanian KV, et al. (2015). N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis. FASEB J 29: 650-61
2. Alhouayek M, Muccioli GG. (2014). Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov Today 19: 1632-9
3. Armirotti A, Romeo E, Ponzano S, et al. (2012). β-Lactones inhibit N-acylethanolamine acid amidase by S-acylation of the catalytic N-terminal cysteine. ACS Med Chem Lett 3: 422-6
4. Arreaza G, Devane WA, Omeir RL, et al. (1997). The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine. Neurosci Lett 234: 59-62
5. Baker D, Pryce G, Croxford JL, et al. (2001). Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J 15: 300-2
6. Bandiera T, Ponzano S, Piomelli D. (2014). Advances in the discovery of N-acylethanolamine acid amidase inhibitors. Pharmacol Res 86: 11-17
7. Bishay P, Schmidt H, Marian C, et al. (2010). R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One 5: e10628
8. Bishop-Bailey D. (2000). Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharmacol 129: 823-34
9. Bisogno T, Martire A, Petrosino S, et al. (2008). Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntingtons disease. Neurochem Int 52: 307-13
10. Braissant O, Foufelle F, Scotto C, et al. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha,-beta, and-gamma in the adult rat. Endocrinology 137: 354-66
11. Capasso R, Izzo A, Fezza F, et al. (2001). Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice. Br J Pharmacol 134: 945-50
12. Cravatt BF, Giang DK, Mayfield SP, et al. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-7
13. Crisafulli C, Cuzzocrea S. (2009). The role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the regulation of inflammation in macrophages. Shock (Augusta, GA) 32: 62-73
14. Delerive P, Gervois P, Fruchart JC, Staels B. (2000). Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J Biol Chem 275: 36703-7
15. Desarnaud F, Cadas H, Piomelli D. (1995). Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem 270: 6030-5
16. De Filippis D, DAmico A, Cinelli MP, et al. (2009). Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats. J Cell Mol Med 13: 1086-95
17. De Filippis D, DAmico A, Cipriano M, et al. (2010). Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. Pharmacol Res 61: 321-8
18. Franklin A, Parmentier-Batteur S, Walter L, et al. (2003). Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 23: 7767-75
19. Fu J, Gaetani S, Oveisi F, et al. (2003). Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425: 90-3
20. Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, et al. (2009). The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol Dis 33: 57-71
21. Gardner O, Dewar B, Graves L. (2005). Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling. Mol Pharmacol 68: 933-41
22. Irukayama-Tomobe Y, Miyauchi T, Kasuya Y, et al. (2004). Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes. J Cardiovasc Pharmacol 44Suppl1: S358-61
23. Issemann I, Green S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-50
24. Izzo A, Capasso R, Aviello G, et al. (2012). Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol 166: 1444-60
25. Kaufmann SHE. (2008). Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff. Nat Immunol 9: 705-12
26. Kiss M, Czimmerer Z, Nagy L. (2013). The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: from physiology to pathology. J Allergy Clin Immunol 132: 264-86
27. Kliewer S, Sundseth SS, Jones SA, et al. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-23
28. Kota BP, Huang THW, Roufogalis BD. (2005). An overview on biological mechanisms of PPARs. Pharmacol Res 51: 85-94
29. Laskin DL, Sunil VR, Gardner CR, Laskin JD. (2011). Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51: 267-88
30. Leung D, Saghatelian A, Simon GM, Cravatt BF. (2006). Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45: 4720-6
31. Liu J, Wang L, Harvey-White J, et al. (2006). A biosynthetic pathway for anandamide. Proc Natl Acad Sci USA 103: 13345-50
32. LoVerme J, Russo R, La Rana G, et al. (2006). Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319: 1051-61
33. LoVerme J, La Rana G, Russo R, et al. (2005). The search for the palmitoylethanolamide receptor. Life Sci 77: 1685-98
34. Magotti P, Bauer I, Igarashi M, et al. (2015). Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids. Struct (London, England: 1993) 23: 598-604
35. Marx N, Mackman N, Schonbeck U, et al. (2001). PPARalpha activators inhibit tissue factor expression and activity in human monocytes. Circulation 103:213-19
36. Mattace-Raso GM, Esposito E, Vitiello S, et al. (2011). Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α. J Neuroendocrinol 23: 591-600
37. Mattace-Raso G, Santoro A, Russo R, et al. (2014). Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats. Endocrinology 155: 1291-301
38. McKinney MK, Cravatt BF. (2005). Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74: 411-32
39. Nagy L, Szanto A, Szatmari I, Szeles L. (2012). Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol Rev 92: 739-89
40. Neve BP, Corseaux D, Chinetti G, et al. (2001). PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation 103:207-12
41. Okamoto Y, Morishita J, Tsuboi K, et al. (2004). Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279: 5298-305
42. Penas F, Mirkin GA, Vera M, et al. (2015). Treatment in vitro with PPARα and PPARγ ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice. Biochim Biophys Acta (BBA) 1852: 893-904
43. Petrosino S, Palazzo E, De Novellis V, et al. (2007). Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology 52: 415-22
44. Petrosino S, Ahmad A, Marcolongo G, et al. (2015). Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain. Pharmacol Res 91: 9-14
45. Ponzano S, Bertozzi F, Mengatto L, et al. (2013). Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors. J Med Chem 56: 6917-34
46. Redlich S, Ribes S, Schütze S, Nau R. (2014). Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections. J Neuroinflammation 11:108
47. Ribeiro A, Pontis S, Mengatto L, et al. (2015). A potent systemically active N-acylethanolamine acid amidase inhibitor that suppresses inflammation and human macrophage activation. ACS Chem Biol 10: 1838-46
48. Richardson D, Pearson RG, Kurian N, et al. (2008). Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 10: R43
49. Rigamonti E, Chinetti-Gbaguidi G, Staels B. (2008). Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men. Arterioscler Thromb Vasc Biol 28: 1050-9
50. Ropero AB, Juan-Picó P, Rafacho A, et al. (2009). Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR alpha ligands in mouse pancreatic islets of Langerhans. J Endocrinol 200: 127-38
51. Sasso O, Moreno-Sanz G, Martucci C, et al. (2013). Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models. Pain 154: 350-60
52. Saturnino C, Petrosino S, Ligresti A, et al. (2010). Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. Bioorg Med Chem Lett 20: 1210-13
53. Schäbitz WR, Giuffrida A, Berger C, et al. (2002). Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33: 2112-14
54. Shu H, Wong B, Zhou G, et al. (2000). Activation of PPARα or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. Biochem Biophys Res Commun 267:345-9
55. Sica A, Mantovani A. (2012). Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-95
56. Simon GM, Cravatt BF. (2008). Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J Biol Chem 283: 9341-9
57. Simon GM, Cravatt BF. (2006). Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 281: 26465-72
58. Skaper SD, Facci L, Giusti P. (2014). Mast cells, glia and neuroinflammation: partners in crime? Immunology 141: 314-27
59. Solorzano C, Zhu C, Battista N, et al. (2009). Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci USA 106: 20966-71
60. Suárez J, Romero-Zerbo Y, Márquez L, et al. (2012). Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids. PLoS One 7: e37729
61. Sun YX, Tsuboi K, Okamoto Y, et al. (2004). Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem J 380: 749-56
62. Tsuboi K, Ikematsu N, Uyama T, et al. (2013). Biosynthetic pathways of bioactive N-acylethanolamines in brain. CNS Neurol Disord Drug Targets 12: 7-16
63. Tsuboi K, Sun XS, Okamoto Y, et al. (2005). Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem 280: 11082-92
64. Tsuboi K, Hilligsmann C, Vandevoorde S, et al. (2004). N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase. Biochem J 379: 99-106
65. Tsuboi K, Zhao LY, Okamoto Y, et al. (2007). Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies. Biochim Biophys Acta Mol Cell Biol Lipids 1771: 623-32
66. Ueda N, Yamanaka K, Terasawa Y, Yamamoto S. (1999). An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. FEBS Lett 454: 267-70
67. Wang J, Okamoto Y, Morishita J, et al. (2006). Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family. J Biol Chem 281: 12325-35
68. West JM, Zvonok N, Whitten KM, et al. (2012). Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition. PLoS One 7: 1-9
69. Zhu C, Solorzano C, Sahar S, et al. (2011). Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages. Mol Pharmacol 79: 786-92